Limited studies suggest improvement, but controlled trials are sparse
Okamoto, A., Yokokawa, H., Nagamine, T., Fukuda, H., Hisaoka, T., & Naito, T
Current short interest of 6.3%or 89,526 of the funds 1.5 million shares outstandingisnt insignificant
11%GLP-1 20244 202677GallupGLP-1 202652865(5,065Gallup Panel1.5)GLP-120243%20258%202611%6%15%GLP-191%202480% (BMI30)202239.9%202636.4%GallupGLP-1202313% GLP-1(Novo NordiskEli Lilly)68%FDA()19% 39%32%77%74% 35%10% GLP-11,000Forbes FDA20266 note
These insights hold considerable significance in conditions such as T2D, where ongoing inflammation and weakened vascular integrity adversely affect the functionality of stem cells
While not formally recognized by conventional medicine, its thought that ongoing stress and a lack of recovery can disrupt cortisol production, leading to symptoms like fatigue, brain fog, and anxiety